HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 35 filers reported holding HORIZON PHARMA INVT LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $280,641,000 | +66.3% | 144,832,000 | 0.0% | 8.17% | +52.7% |
| Q1 2020 | $168,706,000 | -11.9% | 144,832,000 | 0.0% | 5.35% | -12.4% |
| Q4 2019 | $191,529,000 | +21.1% | 144,832,000 | +6.5% | 6.11% | -5.2% |
| Q3 2019 | $158,106,000 | +5.0% | 136,032,000 | 0.0% | 6.45% | +19.2% |
| Q2 2019 | $150,514,000 | +14.5% | 136,032,000 | +17.2% | 5.41% | +7.2% |
| Q1 2019 | $131,460,000 | +16.7% | 116,032,000 | +2.2% | 5.04% | +11.8% |
| Q4 2018 | $112,678,000 | +13.2% | 113,532,000 | +14.6% | 4.51% | +26.5% |
| Q3 2018 | $99,537,000 | +4.9% | 99,100,000 | 0.0% | 3.57% | +7.0% |
| Q2 2018 | $94,914,000 | +4.2% | 99,100,000 | 0.0% | 3.33% | +5.6% |
| Q1 2018 | $91,055,000 | +32.2% | 99,100,000 | +33.7% | 3.16% | +16.4% |
| Q4 2017 | $68,886,000 | +3.0% | 74,100,000 | 0.0% | 2.71% | -10.0% |
| Q3 2017 | $66,895,000 | +4.5% | 74,100,000 | 0.0% | 3.01% | -11.7% |
| Q2 2017 | $64,002,000 | -23.2% | 74,100,000 | -17.8% | 3.41% | +6.3% |
| Q1 2017 | $83,284,000 | +6.3% | 90,100,000 | +9.1% | 3.21% | -0.4% |
| Q4 2016 | $78,342,000 | -2.2% | 82,600,000 | 0.0% | 3.22% | -13.5% |
| Q3 2016 | $80,123,000 | +6.6% | 82,600,000 | 0.0% | 3.73% | +26.1% |
| Q2 2016 | $75,166,000 | +6.7% | 82,600,000 | 0.0% | 2.95% | -1.6% |
| Q1 2016 | $70,475,000 | – | 82,600,000 | – | 3.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|